Blue Cross and Blue Shield of Illinois policies

Search Blue Cross and Blue Shield of Illinois's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

547 public policies Substrate tracks for Blue Cross and Blue Shield of Illinois, by title.

Blue Cross and Blue Shield of Illinois policies
PolicyDetailsCodesSource
AbataceptRX501.113 · Effective Apr 1, 2026 · Commercial, Medicaid1Original policy ↗
Ablation of Peripheral Nerves to Treat PainSUR705.040 · Commercial, Medicaid6Original policy ↗
Absorbable Nasal Implant for Treatment of Nasal Valve CollapseSUR706.017 · Effective Dec 15, 2025 · Commercial, Medicaid1Original policy ↗
ActigraphyMED201.048 · Commercial, Medicaid3Original policy ↗
Adipose-Derived Stem Cells in Autologous Fat Grafting to the BreastSUR716.021 · Commercial, Medicaid5Original policy ↗
Adjustable Cranial Orthoses for Positional Plagiocephaly and CraniosynostosesDME103.007 · Effective Jun 15, 2026 · Commercial, Medicaid2Original policy ↗
Adoptive ImmunotherapyTHE801.024 · Commercial, Medicaid4Original policy ↗
Adult Wellness Guidelines22960.0925 · Commercial, Medicaid · IL—Original policy ↗
Adult Wellness Guidelines (Spanish)23032.0925 · Commercial, Medicaid · IL—Original policy ↗
Aflibercept and Associated Biosimilar(s)OTH903.027 · Commercial, Medicaid11Original policy ↗
Airway Clearance DevicesDME101.027 · Commercial, Medicaid10Original policy ↗
AlemtuzumabRX501.077 · Effective Mar 1, 2026 · Commercial, Medicaid1Original policy ↗
Allergen TestingRPLAB013 · Effective Sep 4, 2026 · Commercial, Medicaid · IL13Original policy ↗
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsSUR703.032 · Commercial, Medicaid67Original policy ↗
Allogeneic Pancreas TransplantSUR703.013 · Commercial, Medicaid5Original policy ↗
Allograft Injection for Degenerative Disc DiseaseSUR705.049 · Effective Dec 15, 2025 · Commercial, Medicaid4Original policy ↗
Ambulance and Transport ServicesMED201.058 · Commercial, Medicaid47Original policy ↗
Amniotic Membrane and Amniotic FluidSUR704.011 · Effective Dec 15, 2025 · Commercial, Medicaid284Original policy ↗
Anesthesia Information – Professional ProviderCPCP010 · Effective Nov 1, 2025 · Commercial, Medicaid · IL11Original policy ↗
Anesthesia Information – Professional ProviderRP010 · Effective Oct 12, 2026 · Commercial, Medicaid · IL11Original policy ↗
Anesthesia Information – Professional ProviderRP010 · Effective Nov 1, 2026 · Commercial, Medicaid · IL11Original policy ↗
Anifrolumab-fniaRX501.138 · Commercial, Medicaid1Original policy ↗
Annulus Closure After DiscectomySUR705.045 · Commercial, Medicaid3Original policy ↗
Antigen Leukocyte Antibody TestMED206.005 · Commercial, Medicaid2Original policy ↗
Antineoplaston Cancer TherapyMED203.002 · Commercial, Medicaid2Original policy ↗
Applied Behavior AnalysisCPCP011 · Effective Mar 20, 2026 · Commercial, Medicaid · IL14Original policy ↗
Aqueous Shunts and Stents for GlaucomaSUR713.034 · Effective Jan 1, 2026 · Commercial, Medicaid15Original policy ↗
Artificial Intervertebral DiscSUR712.028 · Effective Jan 1, 2026 · Commercial, Medicaid12Original policy ↗
Auditory Brainstem ImplantSUR714.009 · Commercial, Medicaid6Original policy ↗
Autografts and Allografts in the Treatment of Focal Articular Cartilage LesionsSUR705.020 · Effective Sep 15, 2026 · Commercial, Medicaid5Original policy ↗
Autologous Chondrocyte Implantation (ACI) for Focal Articular Cartilage LesionsSUR705.035 · Commercial, Medicaid11Original policy ↗
Automated Percutaneous Discectomy and Percutaneous Endoscopic DiscectomySUR712.004 · Effective Oct 15, 2025 · Commercial, Medicaid3Original policy ↗
Autonomic Nervous System (ANS) TestingMED205.034 · Commercial, Medicaid5Original policy ↗
Avacincaptad pegolOTH903.045 · Commercial, Medicaid2Original policy ↗
Axial Lumbosacral Interbody FusionSUR712.038 · Commercial, Medicaid2Original policy ↗
Axillary Reverse Mapping for Prevention of Breast Cancer- Related LymphedemaSUR708.002 · Effective Jan 1, 2026 · Commercial, Medicaid1Original policy ↗
Balloon Dilation of the Eustachian TubeSUR706.018 · Effective Nov 15, 2025 · Commercial, Medicaid2Original policy ↗
Balloon Ostial Dilation for Treatment of Chronic and Recurrent Acute RhinosinusitisSUR706.019 · Effective Sep 15, 2026 · Commercial, Medicaid9Original policy ↗
Bariatric SurgerySUR716.003 · Effective Jan 1, 2026 · Commercial, Medicaid40Original policy ↗
Baroreflex Stimulation DevicesTHE801.034 · Commercial, Medicaid17Original policy ↗
BelataceptRX501.158 · Commercial, Medicaid1Original policy ↗
BelimumabRX501.116 · Effective May 1, 2026 · Commercial, Medicaid1Original policy ↗
BenralizumabRX501.100 · Effective Jan 1, 2026 · Commercial, Medicaid1Original policy ↗
Bioengineered Skin and Soft Tissue SubstitutesSUR704.012 · Effective Jul 1, 2026 · Commercial, Medicaid156Original policy ↗
Biofeedback as a Treatment of Chronic PainPSY301.018 · Effective Jun 15, 2025 · Commercial, Medicaid4Original policy ↗
Biofeedback as a Treatment of Fecal Incontinence or ConstipationPSY301.017 · Commercial, Medicaid6Original policy ↗
Biofeedback as a Treatment of HeadachePSY301.019 · Commercial, Medicaid4Original policy ↗
Biofeedback as a Treatment of Urinary IncontinencePSY301.016 · Commercial, Medicaid7Original policy ↗
Biofeedback for Miscellaneous IndicationsPSY301.007 · Effective Jan 1, 2026 · Commercial, Medicaid4Original policy ↗
Bioimpedance Devices for Detection and Management of LymphedemaMED201.036 · Effective Oct 15, 2025 · Commercial, Medicaid1Original policy ↗

Back to Blue Cross and Blue Shield of Illinois

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.